As an important member of the MAPK signaling pathway, ERK1/2 can directly modify a series of transcription factors that promote cardiac gene expression and ultimately lead to cardiac hypertrophy (Ma et al., 2016). This evidence concerns the gene MAPK3 and cardiac hypertrophy.